White House signed a deal with Pfizer for Covid-19 Treatment Pills worth $5.9 Billion
The White House administration will pay nearly $5.3 billion to drug-maker Pfizer for 10 million treatment courses of its potential COVID-19 treatment after the approval from regulators. Pfizer asked the FDA (Food and Drug Administration) to authorize the experimental pill, called Paxlovid. The company said earlier this month that Paxlovid cut the risk of hospitalization […]